One June 6, 2018, the U.S. Food and Drug Administration (FSDA) issued a Class 1 recall alert for CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope Corp. due to a design issue that allows fluid (such as saline) to seep into the device.
“The fluid can cause corrosion of internal components such as the electronic circuit boards, and lead to device malfunction (e.g., sudden stops) which can cause a delay or interruption in therapy. Device failure may result in immediate and serious adverse health consequences, including death.”
Table of Affected Devices
|CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope Corp.|
Recommendations for Users:
- Never place fluids on top of the unit
- Ensure that the saline container and tubing do not hang directly over the IABP
- In case of accidental spillage, to wipe clean immediately and have the unit serviced to ensure no hazard exists.
In case of an interruption in therapy, the letter instructed users to:
- Transfer the patient to an alternative IABP
- If an alternative IABP is unavailable:
- manually inflate the IAB with air or helium and immediately aspirate
- repeat every 5 minutes until either an alternate IABP is available or alternatively (i.e., if an alternative IABP is not available in a reasonable amount of time) the intra-aortic balloon catheter should be removed from the patient.
The FDA stated that affected customers will be contacted by Maquet Datascope Corp. to schedule on-site service of the IABP by a Maquet Datascope Corp. sales or service representative. The company anticipates having the protective top cover available by late June 2018.
Customer in the United States who seek more information about this recall can contact Maquet Datascope Corp.’s Technical Support Department at 1-888-627-8383 (press option 3), Monday through Friday, between 8 a.m. and 6 p.m. Eastern Standard Time.
The FDA encourages healthcare professionals and patients to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program at www.fda.gov/MedWatch/report or call 1-800-332-1088 to request a reporting form.